Related Experiment Video
Updated: Jun 25, 2026
09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma
Gloria S Huang1, Rebecca C Arend, Maomi Li
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA.
American Journal of Obstetrics and Gynecology
|February 10, 2009
Summary
Uterine carcinosarcoma shows increased estrogen receptor beta and human epidermal growth factor receptor 2 expression, correlating with disease progression. Estrogen receptor alpha and progesterone receptor are suppressed, suggesting potential therapeutic targets.
Area of Science:
- Gynecologic Oncology
- Molecular Pathology
- Cancer Biomarkers
Background:
- Uterine carcinosarcoma is an aggressive malignancy with complex molecular underpinnings.
- Hormone and growth factor receptor expression patterns are crucial for understanding tumor behavior and progression.
Purpose of the Study:
- To investigate the association between key hormone receptors (estrogen receptor alpha, estrogen receptor beta, progesterone receptor) and growth factor receptors (insulin-like growth factor receptor, human epidermal growth factor receptor 2) with disease progression in uterine carcinosarcoma.
Main Methods:
- Immunohistochemistry was utilized on tissue arrays to assess receptor expression.
- Statistical analyses, including Wilcoxon rank-sum test and linear trend analysis, were employed to evaluate differences and interactions.
Main Results:
- Uterine carcinosarcomas demonstrated significantly lower estrogen receptor alpha and progesterone receptor expression compared to normal endometrium.
- Estrogen receptor beta was overexpressed and its expression increased with advanced disease stage.
- Human epidermal growth factor receptor 2 expression was elevated and positively correlated with disease progression, while insulin-like growth factor receptor was lower than in normal endometrium.
Conclusions:
- Estrogen receptor beta and human epidermal growth factor receptor 2 are implicated in uterine carcinosarcoma progression.
- Suppressed estrogen receptor alpha and progesterone receptor suggest altered hormonal signaling.
- The findings support a potential role for estrogen receptor beta in disease progression, possibly through crosstalk with human epidermal growth factor receptor 2.
